Skip to main navigation Skip to search Skip to main content

A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of GS-9883/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in HIV-1 Infected, Antiretoviral Treatment-Naive Adults

Project: Research

Project Details

StatusFinished
Effective start/end date04/6/16 → 04/5/20

Funding

  • Gilead Sciences Incorporated: $23,190.00